COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors - 04/08/21
, Y. Bansal c
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
Clinical management protocols for COVID-19 are evolving rapidly as more information about the epidemiology and pathophysiological changes in COVID-19 become available. However, no definite treatment of COVID-19 has been found till date. The COVID-19 convalescent plasma (CCP) therapy has emerged as an important investigational therapy in the management of COVID-19 patients. Additionally, the regulatory agencies, in particular, the Indian blood transfusion council must release some interim recommendations for the blood centres on the CCP blood donor eligibility criteria after COVID-19 vaccination. More clinical trials are needed to know the efficacy of the CCP harvested from COVID-19 recovered individuals who have been vaccinated against those COVID-19 recovered individuals who are not vaccinated to understand the vaccine impact on the IgG titres of anti-SARS-CoV-2 antibodies.
El texto completo de este artículo está disponible en PDF.Keywords : Vaccine impact, Pandemic, Blood donors, Deferral, COVID-19, Blood centre
Esquema
Vol 28 - N° 3
P. 308-309 - août 2021 Regresar al número
Artículo precedente
- Blood Donation during COVID-19 Vaccination drive - The Need for Concern
- Tarun Kumar Suvvari, L.V. Simhachalam Kutikuppala, Naga Alekhya Garikipati, Sai Venkata Kalyani Ponnaganti, Venkata Ramana Kandi
- Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
- Massimo Franchini, Claudia Glingani, Angela Bellani, Nicola Cicorella, Alessandro Amadini, Giuseppe De Donno, Salvatore Casari
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.